Goldman Sachs lowered the firm’s price target on Ibotta (IBTA) to $23 from $26 and keeps a Sell rating on the shares. The “LiveLift” platform transition remains a work in progress, the analyst tells investors in a research note.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IBTA:
- Ibotta, Inc. Class A: Hold Rating Amid Promising Initiatives and Macroeconomic Challenges
- Cautious Outlook for Ibotta, Inc. Amid Revenue Decline and Uncertain LiveLift Initiative
- Ibotta, Inc. Reports Q3 2025 Financial Results
- Ibotta reports Q3 adjusted EPS 56c, two estimates 34c
- Ibotta sees Q4 revenue $80M-$85M, consensus $84.3M